BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 25131257)

  • 1. Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator.
    Silakit R; Loilome W; Yongvanit P; Chusorn P; Techasen A; Boonmars T; Khuntikeo N; Chamadol N; Pairojkul C; Namwat N
    J Hepatobiliary Pancreat Sci; 2014 Dec; 21(12):864-72. PubMed ID: 25131257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group.
    Silakit R; Loilome W; Yongvanit P; Thongchot S; Sithithaworn P; Boonmars T; Koonmee S; Titapun A; Khuntikeo N; Chamadol N; Techasen A; Namwat N
    Parasitol Int; 2017 Aug; 66(4):479-485. PubMed ID: 26456596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis.
    Loilome W; Wechagama P; Namwat N; Jusakul A; Sripa B; Miwa M; Kuver R; Yongvanit P
    Parasitol Int; 2012 Mar; 61(1):136-9. PubMed ID: 21763455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel carbohydrate antigen expression during development of Opisthorchis viverrini- associated cholangiocarcinoma in golden hamster: a potential marker for early diagnosis.
    Sawanyawisuth K; Silsirivanit A; Kunlabut K; Tantapotinan N; Vaeteewoottacharn K; Wongkham S
    Parasitol Int; 2012 Mar; 61(1):151-4. PubMed ID: 21784171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma.
    Boonjaraspinyo S; Wu Z; Boonmars T; Kaewkes S; Loilome W; Sithithaworn P; Nagano I; Takahashi Y; Yongvanit P; Bhudhisawasdi V
    Parasitol Int; 2012 Mar; 61(1):145-50. PubMed ID: 21777692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis.
    Chusorn P; Namwat N; Loilome W; Techasen A; Pairojkul C; Khuntikeo N; Dechakhamphu A; Talabnin C; Chan-On W; Ong CK; Teh BT; Yongvanit P
    Tumour Biol; 2013 Jun; 34(3):1579-88. PubMed ID: 23417858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model.
    Loilome W; Yongvanit P; Wongkham C; Tepsiri N; Sripa B; Sithithaworn P; Hanai S; Miwa M
    Mol Carcinog; 2006 May; 45(5):279-87. PubMed ID: 16550611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma.
    Yongvanit P; Pinlaor S; Loilome W
    J Hepatobiliary Pancreat Sci; 2014 May; 21(5):309-15. PubMed ID: 24408859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum antibody response to Opisthorchis viverrini antigen as a marker for opisthorchiasis-associated cholangiocarcinoma.
    Akai PS; Pungpak S; Chaicumpa W; Viroj K; Bunnag D; Befus AD
    Trans R Soc Trop Med Hyg; 1994; 88(4):471-4. PubMed ID: 7570848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations of KRAS and TP53 in a minor proportion of Opisthorchis viverrini-associated cholangiocarcinomas in a hamster model.
    Tangkawattana S; Kaewkes S; Pairojkul C; Tangkawattana P; Sripa B
    Asian Pac J Cancer Prev; 2008; 9(1):101-6. PubMed ID: 18439086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsets of Inflammatory Cytokine Gene Polymorphisms are Associated with Risk of Carcinogenic Liver Fluke
    Surapaitoon A; Suttiprapa S; Mairiang E; Khuntikeo N; Pairojkul C; Bethony J; Brindley PJ; Sripa B
    Korean J Parasitol; 2017 Jun; 55(3):295-304. PubMed ID: 28719954
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma phosphoproteome and differential plasma phosphoproteins with opisthorchis viverrini-related cholangiocarcinoma.
    Kotawong K; Thitapakorn V; Roytrakul S; Phaonakrop N; Viyanant V; Na-Bangchang K
    Asian Pac J Cancer Prev; 2015; 16(3):1011-8. PubMed ID: 25735322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma.
    Wang LJ; Zhang KL; Zhang N; Ma XW; Yan SW; Cao DH; Shi SJ
    Oncotarget; 2015 Jul; 6(21):18631-40. PubMed ID: 26087181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma.
    Sudsarn P; Boonmars T; Ruangjirachuporn W; Namwat N; Loilome W; Sriraj P; Aukkanimart R; Nadchanan W; Jiraporn S
    Pathol Oncol Res; 2016 Jan; 22(1):57-65. PubMed ID: 26277607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group.
    Loilome W; Yooyuen S; Namwat N; Sithithaworn P; Puapairoj A; Kano J; Noguchi M; Miwa M; Yongvanit P
    Tumour Biol; 2012 Dec; 33(6):2289-98. PubMed ID: 22922884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients.
    Chamadol N; Pairojkul C; Khuntikeo N; Laopaiboon V; Loilome W; Sithithaworn P; Yongvanit P
    J Hepatobiliary Pancreat Sci; 2014 May; 21(5):316-22. PubMed ID: 24420706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Potential Biomarkers for
    Aksorn N; Roytrakul S; Kittisenachai S; Leelawat K; Chanvorachote P; Topanurak S; Hamano S; Lek-Uthai U
    In Vivo; 2018; 32(4):871-878. PubMed ID: 29936472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholangiocarcinoma in experimental hamsters with long-standing Opisthorchis viverrini infection.
    Songserm N; Prasongwattana J; Sithithaworn P; Sripa B; Pipitkool V
    Asian Pac J Cancer Prev; 2009; 10(2):299-302. PubMed ID: 19537899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis.
    Techasen A; Loilome W; Namwat N; Duenngai K; Cha'on U; Thanan R; Sithithaworn P; Miwa M; Yongvanit P
    Parasitol Int; 2012 Mar; 61(1):140-4. PubMed ID: 21763456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.